FDA Drug Application (021275) for LUMIGAN by ALLERGAN

Back to FDA Applications sponsored by ALLERGAN

Application Number021275
Product Number001
FormSOLUTION/DROPS;OPHTHALMIC
Dosage0.03% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLUMIGAN
Active IngredientBIMATOPROST

Active IngredientCount
List of drugs with Active Ingredient BIMATOPROST3


Back to FDA Applications sponsored by ALLERGAN